Search research articles
Contact Us
Filters
Showing results (171-180 of 189) with videos related to
Page
of 19
Sort By:
The Journal of Biological Chemistry
|
May 25, 2001
Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists
J M Way, C Z Görgün, Q Tong, et al.
Molecular Endocrinology (Baltimore, Md.)
|
November 3, 2007
Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonist
Barry G Shearer, David J Steger, James M Way, et al.
Biological Psychiatry
|
March 30, 2016
Alterations in Resting-State Functional Connectivity Link Mindfulness Meditation With Reduced Interleukin-6: A Randomized Controlled Trial
J David Creswell, Adrienne A Taren, Emily K Lindsay, et al.
The American Journal of Clinical Nutrition
|
May 1, 1982
Hypercalcemia associated with parenteral amino acid and dextrose infusion
J E Gilligan, S Hagley, L I Worthley, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 30, 2008
Discovery of a novel class of PPARdelta partial agonists
Barry G Shearer, Hari S Patel, Andrew N Billin, et al.
The British Journal of Dermatology
|
December 20, 2019
Skin cancer multiplicity in lung transplant recipients: a prospective population-based study
M Way, L Marquart, D C Chambers, et al.
Nature Human Behaviour
|
June 16, 2025
The earliest evidence of high-elevation ice age occupation in Australia
Amy M Way, Philip J Piper, Rebecca Chalker, et al.
Journal of Geophysical Research. Space Physics
|
March 20, 2018
Plasma observations during the Mars atmospheric "plume" event of March-April 2012
D J Andrews, S Barabash, N J T Edberg, et al.
Journal of Lipid Research
|
October 9, 2001
Effects of fenofibrate on lipid parameters in obese rhesus monkeys
D A Winegar, P J Brown, W O Wilkison, et al.
Journal of Medicinal Chemistry
|
February 5, 2010
Identification and characterization of 4-chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a selective and irreversible peroxisome proliferator-activated receptor delta (PPARdelta) antagonist
Barry G Shearer, Robert W Wiethe, Adam Ashe, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 189) with videos related to
Sort By:
Page
of 19
The Journal of Biological Chemistry
|
May 25, 2001
Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists
J M Way, C Z Görgün, Q Tong, et al.
Molecular Endocrinology (Baltimore, Md.)
|
November 3, 2007
Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonist
Barry G Shearer, David J Steger, James M Way, et al.
Biological Psychiatry
|
March 30, 2016
Alterations in Resting-State Functional Connectivity Link Mindfulness Meditation With Reduced Interleukin-6: A Randomized Controlled Trial
J David Creswell, Adrienne A Taren, Emily K Lindsay, et al.
The American Journal of Clinical Nutrition
|
May 1, 1982
Hypercalcemia associated with parenteral amino acid and dextrose infusion
J E Gilligan, S Hagley, L I Worthley, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 30, 2008
Discovery of a novel class of PPARdelta partial agonists
Barry G Shearer, Hari S Patel, Andrew N Billin, et al.
The British Journal of Dermatology
|
December 20, 2019
Skin cancer multiplicity in lung transplant recipients: a prospective population-based study
M Way, L Marquart, D C Chambers, et al.
Nature Human Behaviour
|
June 16, 2025
The earliest evidence of high-elevation ice age occupation in Australia
Amy M Way, Philip J Piper, Rebecca Chalker, et al.
Journal of Geophysical Research. Space Physics
|
March 20, 2018
Plasma observations during the Mars atmospheric "plume" event of March-April 2012
D J Andrews, S Barabash, N J T Edberg, et al.
Journal of Lipid Research
|
October 9, 2001
Effects of fenofibrate on lipid parameters in obese rhesus monkeys
D A Winegar, P J Brown, W O Wilkison, et al.
Journal of Medicinal Chemistry
|
February 5, 2010
Identification and characterization of 4-chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a selective and irreversible peroxisome proliferator-activated receptor delta (PPARdelta) antagonist
Barry G Shearer, Robert W Wiethe, Adam Ashe, et al.
Page
of 19